Beta-2-microglobulin-associated amyloidosis

Nephron

Volumn 72, Issue 1, 1996, Pages 9-26

  Floege, Jürgen ^a   Ehlerding, Götz ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Amyloidosis; Beta 2 microglobulin; Hemodialysis Peritoneal dialysis; Renal failure

Indexed keywords

BETA 2 MICROGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; CASE REPORT; CLINICAL FEATURE; DIALYSIS; HEMODIALYSIS; HUMAN; KIDNEY AMYLOIDOSIS; MALE; MORBIDITY; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYNDROME;

AMYLOID; AMYLOIDOSIS; BETA 2-MICROGLOBULIN; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; OSTEOARTHROPATHY, SECONDARY HYPERTROPHIC; RADIONUCLIDE IMAGING; RENAL DIALYSIS; UREMIA; X-RAYS;

EID: 0030050003     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188801     Document Type: Article

References (220)

1. Assenât H, Calemard H, Charra B, Laurent G, Terret JC. Vanel T: Hémodialyse, syndrome du canal carpien et substance amyloïde. Nouv Presse Méd 1980:9:1715.
2. Gejyo F, Yamada T. Odani S. Nakagawa Y, Arakawa M. Kunitomo T. Kataoka H. Suzuki M. Hirasawa Y. Shirahama T. Cohen AS, Schmidt K: A new form of amyloid protein associated with chronic hemodialysis was identified as beta-2-microglobulin. Biochem Bio-phys Res Commun 1955; 129:701-706.
3. Shirahama T, Skinner M. Cohen AS. Gejyo F. Arakawa M, Suzuki M, Hirasawa A: Histo-chcmical and immunohistochemical characterization of amyloid associated with chronic hemodialysis asbeta-2-microglobulin. Lab Invest 1985;53:705-709.
4. Linkc RP, Bommcr J, Ritz E. Waldherr R. Eulitz M: Amyloid kidney stones of uremic patients consist of beta-2-microglobulin fragments. Biochem Biophys Res Commun 1986; 136:665-671.
5. Morinière P, Marie A. el Esper N. Fardellone P. Dcramond H. Rémond A. Sebert JL. Fournier A: Destructive spondyloarthropathy with bcta-2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis. Nephron 1991:59:654-657.
6. Koch KM: Dialysis-related amyloidosis (clinical conference). Kidney Int 1992:41:1416-1429.
7. Charra B. Calemard E, Laurent G: Chronic renal failure treatment duration and mode: Their relevance to the late dialysis periarticular syndrome. Blood Purif 1988:6:117-124.
8. Gejyo F, Homma N. Arakawa M: Carpal tunnel syndrome and beta-2-microglobulin-rclated amyloidosis in chronic hemodialysis patients. Blood Purif 1988;6:125-131.
9. Gravallcsc EM. Baker N, Lestcr S. Kay J. Owen WJ: Musculoskeletal manifestations in bcta-2-microglobulin amyloidosis: Case discussion (clinical conference). Arthritis Rheum 1992: 35:592-602.
10. Kleinman KS, Cobum JW: Amyloid syndromes associated with hemodialysis. Kidney Int 1989;45:567-575.
11. Laurent G, Calemard E. Charra B: Dialysis related amvloidosis. Kidney Int 1988;24:S32-S34.
12. van Yperscle de Strihou C, Honhon BV, Van-denbroucke JM. Huaux JP, Noel H, Maldague B: Dialysis amyloidosis. Adv Nephrol 1988:17: 401-422.
13. Bardin T, Zingraff J, Kuntz D. Drucke T: Dialysis-Related Amyloidosis. Nephrol Dial Transplant 1986;1:151-154.
14. Bardin T. Kuntz D, Zingraff J, Voisin M-C, Zeltrar A. Lansaman J: Synovial amyloidosis in patients undergoing long-term hemodialysis. Arthritis Rheum 1985;28:1052-1058.
15. Bardin T. Zingraff J. Shirahama T, Noel LH. Droz D. Voisin MC. Drueke T, Dryll A. Skinner M. Cohen AS, Kuntz D: Hemodialysis-associated amyloidosis and beta-2 microglobulin. Clinical and immunohistochemical study. Am J Med 1987;83:419-424.
16. Sethi D. Morgan TC. Brown EA, Cary NR, Erhardt CC, Pazianas M, Maini RN, Woodrow DF, Gower PE: Dialysis arthropathy: A clinical. biochemical, radiological and histological study of 36 patients. Q J Med 1990:77:1061-1082.
17. Hurst NP. van den Berg R, Disney A, Alcock M. Albertyn L. Green M, Pascoe V: Dialysis related arthropathy': A survey of 95 patients receiving chronic haemodialysis with special reference to beta 2-microglobulin related amyloidosis. Ann Rheum Dis 1989:48:409-420.
18. Munoz Gomez J. Gomez PR. Llopart BE. Sole AM: Clinical picture of the amyloid arthropathy in patients with chronic renal failure maintained on haemodialysis using cellulose membranes. Ann Rheum Dis 1987:46:573-579.
19. Stein G. Schneider A, Thoss K. Ritz E. Linke RP. Schaefer K. Sperschneider H. Abcndrolh K. Fiinfstuck R: Beta-2-microglobulin-derivcd amyloidosis: Onset, distribution and clinical features in 13 hemodialysis patients. Nephron 1992:60:274-280.
20. Athanasou NA, Ayers D. Rainey AJ, Oliver DO. Duthie RB: Joint and systemic distribution of dialysis amyloid. Q J Med 1991:78: 205-214.
21. Zingraff J. Noel LH, Bardin T. Kuntz D. Du-bost C. Drueke T: Beta 2-microglobulin amyloidosis: A sternoclavicular joint biopsy study in hemodialysis patients. Clin Nephrol 1990; 33:94-97.
22. Sethi D. Maher ER. Cary NRB: Dialysis related amyloidosis presenting as acute arthritis. Nephron 1988:50:73-74.
23. Sargent MA. Fleming SJ, Chattopadhyay C. Ackrill P. Sambrook P: Bone cysts and haemodialysis-related amyloidosis. Clin Radiol 1989: 40:277-281.
24. DiRaimondo CR. Casey TT. DiRaimondo CV, Stone W: Pathological fractures associated with idiopathic amyloidosis of bone in chronic hemodialysis patients. Nephron 1986:43:22-27.
25. Campistol JM. Sole M. Munoz Gomez J. Riba J, Ramon R. Revert L: Pathological fractures in patients who have amyloidosis associated with dialysis: A report of five cases. J Bone Joint Surg 1990:72:568-574.
26. Scheumann GF. Hold M. Nerlich MI. Brandis A. Ostertag H. Tscheme H: Pathological fractures and lytic bone lesion of the femoral neck associated with beta-2-microgtobulin amyloid deposition in long-term dialysis patients. Arch Orthop Trauma Surg 1991:110: 93-97.
27. Giclen JL. Van Holsbeek MT. Hauglustaine D. Verresen I. Verbecken E. Baert AL. Meeus E, Vandevoorde P. Michielsen P. Coral A: Growing bone cysts in long-term hemodialysis. Skeletal Radiol 1990:19:43-49.
28. Van Ypcrsele de Strihou C. Jadoul M. Mal-ghent J. Maldague B, Jamart J: Effect of dialysis menibraneand patient’s age on signs ofdialysis-related amyloidosis: The Working Party on Dialysis Amyloidosis. Kidney Int 1991:39: 1012-1019.
29. Pitt MJ. Graham AR. Shipman JH. Birkby W: Herniation pit of the femoral neck. Am J Radiol 1982;138:1115-1121.
30. Fenves AZ, Emmett M. White MG, Greenway G. Michaels DB: Carpal tunnel syndrome w ith cystic bone lesions secondary to amyloidosis in chronic hemodialysis patients. Am J Kidnev Dis 1986:7:130-134.
31. Sole M. Cardesa A. Palacin A. Munoz M, Gomez J. Campistol JM: Morphological and immunohistochemical findings in dialysis-related amyloidosis: An analysis of 16 cases. Appl Pathol 1989;7:350-360.
32. Ehlerding G. Floege J, Drommer W. Koch KM: No evidence for inflammatory or fibrotic synovial changes prior to deposition of dialysis related amyloidosis. J Am Soc Nephrol 1993:4: 344.
33. Noel LH. Zingraff J. Bardin T. Atienza C. Kuntz D. Drueke T: Tissue distribution of dialysis amyloidosis. Clin Nephrol 1987:27:175-178.
34. Ayers DC. Athanasou NA. Woods CG. Dulhic RB: Dialysis arthropathy of the hip. Clin Orthop 1993:290:216-224.
35. Eusenti T, Borgatti PP. Lindner G. Atielli A. Brancaccio D: Multiple tendineal tumoral amyloid masses in a patient on long-term dialysis (letter). Nephron 1991:57:243-244
36. Onishi S. Andress DE. Maloney NA. Coburn JW. Shcrrard DJ: Beta-2-microglobulin deposition in bone in chronic renal failure. Kidney Int 1991:39:990-995.
37. Kuntz D. Naveau B. Bardin T. Drueke T, Treves R. Dryll A: Destaictivc spondylar-thropathy in hemodialvscd patients: A new syndrome. Arthritis Rheum 1984:167:369-375.
38. Gerster JC. Carruzzo PA. Ginalski JM. Wau-ters JP: Cervicooccipital hinge changes during long-term hemodialysis. J Rheumatol 1989:16: 1469-1473.
39. Sundaram M. Dessner D. Ballal S: Solitary, spontaneous cervical and large bone fractures in aluminum osteodystrophy. Skeletal Radiol 1991:20:91-94.
40. Naidich JB. Mossey RT. McHeffey-Atkinson B. Karmel ME Bluestone PA. Mailloux LU. Stein HE: Spondylarthropathy from long-term hemodialysis. Radiology 1988:167:761-764.
41. Cornelis F. Bardin T. Fallcr B. Verger C. Al-louache M. Raymond P. Rottembourg J. Tour-lière D, Benhamou C, Noel EH. Kuntz D: Rheumatic syndromes and beta-2-microglobu-lin amyloidosis in patients receiving long-term peritoneal dialysis. Arthritis Rheum 1989:32: 785-788.
42. Alcalay M. Goupy MC. Azais I. Bontoux D: Hemodialysis is not essential for the development of destructive spondylarthropathy in patients with chronic renal failure. Arthritis Rheum 1987:30:1182-1186.
43. Miguel Alonso J. Cruz A. Lopcz Revuella K. Caparros G. Gonzales T, Munoz M, Gomez J. Martinez ME. Selgas R: Continuous ambulatory peritoneal dialysis does not prevent the development of dialysis-associated amyloidosis. Nephron 1989;53:389-390.
44. Cruz A. Gonzales T. Balsa A. Miguel LJ. Gijon J: Destructive spondylarthopathy in long-term CAPD and hemodialysis. J Rheumatol 1986: 16:1169-1170.
45. Bindi P. Chanard J: Destructive spondyloarthropathy in dialysis patients: An overview. Nephron 1990:55:104-109.
46. Wullbrand A. Saeger W. Missmahl HP. Voigt C. Linke RP: Amyloid in intervertebral discs of surgery and autopsy material: A new class of amyloid? Virchows Arch [A] 1990:416:335-341.
47. Mohr W. Kuhn C. Linke RP. Wessinghage D: Deposition of amyloid of unknown origin in articular cartilage. Virchows Arch [B] 1991:60: 259-262.
48. Sebert LJ, Fardellone P. Marie A. Deramond H. Lambrey G. Legars D. Galibert P. Smajda A. Fournier A: Destructive spondylarthropathy in hemodialyzed patients: Possible role of amyloidosis. Arthritis Rheum 1986:29:301-303.
49. Ohashi K. Ilara M. Kawai R. Ogura Y. Honda K. Nihci II, Mimura N: Cervical discs arc most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column. Kidney Int 1992:41:1646-1652.
50. Kroner G. Stabler A. Seiderer M. Moran JE, Gurland HJ: Beta-2-microglobulin-related amyloidosis causing atlantoaxial spondylarthropathy with spinal-cord compression in haemodialysis patients: Detection by MRI. Nephrol Dial Transplant 1991;6:91-95.
51. Welk LA. Quint DJ: Amyloidosis of the spine in a patient on long-term hemodialysis. Neuroradiology 1990:32:334-336.
52. Kessler M. Netter P, Grignon B. Bertheau JM. Aymard B. Azoulay E. Gaucher A: Destructive beta 2-microglobulin amyloid arthropathy of the ccrvico-occipital hinge in a hemodialyzed patient (letter). Arthritis Rheum 1990:33:602-604.
53. Allain TJ, Stevens PE. Bridges LR. Phillips ME: Dialysis myelopathy: Quadriparesis due to extradural amyloid of beta-2-microglobulin origin. BrMed J 1988;296:752-753.
54. Kurcr MIL Baillod RA. Madgwick JC: Musculoskeletal manifestations of amyloidosis: A review of 83 patients on haemodialysis for at least lOvears. J Bone Joint Surg 1991:73:271-276.
55. Corradi M. Paganelli E, Pavcsi G: Carpal tunnel syndrome in long-term hemodialyzed patients. J Reconst r Microsurg 1989:5:103-110.
56. Kessler M. Netter P, Azoulay E. Mayeux D, Père P. Gaucher A: Dialysis-associated arthropathy: A multicentre survey of 171 patients receiving haemodialysis for over 10 years. The Cooperative Group on Dialysis-associated Arthropathy. Br J Rheumatol 1992: 31:157-162.
57. McClure J. Bartley CJ, Ackrill P: Carpal tunnel syndrome caused by amyloid containing beta-2-microglobulin: A new amyloid and a complication of long-term haemodialysis. Ann Rheum Dis 1986:45:1007-1011.
58. Schwartz A. Keller F, Seyfert S. Poll W. Mol-zahn M. Distler A: Carpal tunnel syndrome: A major complication in long-term hemodialysis patients. Clin Nephrol 1984;22:133-137.
59. Corradi M, Paganelli E, Pavesi G: Internal neurolysis and flexor tenosynovectomy: Adjuncts in the treatment of chronic median nerve compression at the wrist in hemodialysis patients. Microsurgery 1989;10:248-250.
60. Bommcr J. Waldherr R. Andrassy K. Ritz E: Carpal tunnel syndrome in dialysis patients. No evidence for amyloidosis (abstract). Kidney Int 1985:28:711.
61. Curette S, Hazleman B: Regional pain problems. Soft tissue: Entrapment neuropathies: in Klippel JM, Dieppe PA (eds): Rheumatology. Dindon. Mosby-Year Europe. 1994. pp 19.1-19.7.
62. Branz NR. Newton RA: Hand function in patients on maintenance hemodialysis. PhysTher 1988:68:1092-1097.
63. Sethi D, Hutchison AJ. Cary NR. Brown EA. Curtis JR. Woodrow DF. Gowcr PE: Macro-glossia and amyloidoma of the buttock: Evidence of systemic involvement in dialysis amyloid. Nephron 1990:55:312-315.
64. Reese W, Hopkovitz A. Lifschitz MD: Beta-2-microglobulin and associated amyloidosis presenting as bilateral popliteal tumors. Am J Kidney Dis 1988;12:323-325.
65. Floege J. Brandis A. Nonnast Daniel B. West-holï Bleck M. Tiedow G. Linke RP. Koch KM: Subcutaneous amvloid-tumor of beta-2-micro-globulin origin in a long-term hemodialysis patient. Nephron 1989:53:73-75.
66. Brancaccio D. Gallieni M. Padovese P. Anelli A. Coggi G. Uslcnghi C: Dialysis amyloidosis with massive popliteal deposition of beta-2-microglobulin amyloid (letter). Lancet 1988;Vol ii: 802.
67. Varga J. Idelson BA. Felson D, Skinner M. Cohen AS: Lack of amyloid in abdominal fat aspirates from patients undergoing long-term hemodialysis. Arch Intern Med 1987; 147: 1455-1457.
68. Sethi D. Cary NR. Brown EA, Woodrow DF. Gower PE: Dialysis-associated amyloid: Systemic or local? Nephrol Dial Transplant 1989; 4:1054-1059.
69. Takahashi S. Morita T. Koda Y. Murayama H. Hirasawa Y: Gastrointestinal involvement of dialysis-related amyloidosis. Clin Nephrol 1988:30:168-171.
70. Campistol JM. Cases A. Torras A, Sole M, Munoz Gomez J. Monloliu J. Lopez Pedret J. Revert L: Visceral involvement of dialysis amyloidosis. Am J Nephrol 1987;7:390-393.
71. Mazanec K. McClure J. Bartley CJ. Newbould MJ. Ackrill P: Systemic amyloidosis of beta-2-microglobulin type. J Clin Pathol 1992:45: 832-833.
72. Ogawa II. Saito A, llirabayashi N, Hara K: Amyloid deposition in systemic organs in longterm hemodialysis patients. Clin Nephrol 1987:28:199-204.
73. Maher ER. Dutoit SI I. Baillod R A. Sweny P. Moorhead JF: Gastrointestinal complications of dialysis related amyloidosis. Br Med J 1988; 297:265-266.
74. Shinoda T. Komatsu M. Aizawa T, Shirota T, Yamada T, Ehara T. Mizukami E: Intestinal pseudo-obstruction due to dialysis amyloidosis. Clin Nephrol 1989:32:284-289.
75. Arakawa M. Geijyo F. Oohara K. Momma N: Systemic deposition of beta-2-microglobulin amyloid; in Gejyo F. Brancaggio D. Bardin T (eds): Dialysis Amyloidosis. Milan. Wichtig Editore, 1989. pp 111-118.
76. Fuchs A. Jagirda J. Schwartz IS: Beta-2-micro-globulin amyloidosis in patients undergoing long-term hemodialysis. Am J Clin Pathol 1987:88:302-307.
77. Ozasa II, Suzuki T. Takahashi K. Ota K: Protein components of amyloid-like kidney stones of chronic hemodialysis patients. Nephron 1989:53:257-260.
78. Watanabe K. Nakamura R. Kano S. Ohtakc T. Hosoda Y. Saruta T: Amyloid urinary-tract calculi in patients on chronic dialysis. Nephron 1989;52:334-337.
79. Zingraff J.I. Noel LH, Bardin T, Atienza C. Zins B, Drueke TB. Kuntz D: Beta-2-micro-globulin amyloidosis in chronic renal failure (letter). N Engl J Med 1990:323:1070-1071.
80. l3ll-beta-2-microglobu-lin. Nephron 1989:51:444-447.
81. Floege J. Burchert W. Brandis A. Gielow P. Nonnast Daniel B. Spindler E, Hundeshagen H. Shaldon S. Koch KM: Imaging of dialysis-related amyloid (AB-amyloid) deposits with 1-beta-2-microglobulin. Kidney Int 1990:38: 1169-1176.
82. Chanard J. Bindi P. Lavaud S. Toupancc O. Maheut H. Lacour F: Carpal tunnel syndrome and type of dialysis membrane. Br Med J 1989: 298:867-868.
83. Renaud H. Foumière A, Morinière P. Westeei P. El Esper N. Belbrik S. Marie A. Cohen-Solal H. Sebert J: Erosive osteoarthropathy associated with beta-2-microglobulin in a uremic patient treated exclusively by long-term hemofiltration with biocompatible membranes. Nephrol Dial Transplant 1988:3:820-822.
84. Jadoul M, Noel H. van Ypcrsele de Strihou C: Beta-2-microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1990:15: 86-88.
85. Schaeffer J. Ehlerding G, Burchert W. Floege J. Shaldon S. Koch KM: Relationship of scintigraphic-ally proven dialysis-related amyloidosis to age and time on hemodialysis (abstract). J Am Soc Nephrol 1992:3:392.
86. Athanasou NA. Chaplin AJ. Oliver DO: Subcutaneous deposition of beta-2-microglobulin amyloid in a long-term haemodialysis patient. Nephrol Dial Tranplant 1990:5:878-881.
87. Yver L. Blanchier D. Buiquang D. Caban ne JF. Charmes JP. Mefthahi II: Docs aluminum induce dialysis amyloidosis? Nephrol Dial Transplant 1987;2:450-451.
88. Canavese C. Pacitti A. Portigliatti M. Viglino C. Cadario A. Gurioli L. Fomi M. Cirolla MG. Costantini S. Giordano R: Aluminium and dialysis arthropathy (letter). Nephron 1990:56: 455-456.
89. Cary NR. Sethi D, Brown EA. Erhard! CC, Woodrow DF. Gower PE: Dialysis arthropathy: Amyloid or iron? Br Med J 1986:293: 1392-1394.
90. Glcnner G: Amyloid deposits and amyloidosis: The ß-fibrillosis (second of two parts). N Engl J Med 1980:302:1333-1343.
91. Gleaner G: Amyloid deposits and amyloidosis: l'he P-librillosis (first of two parts). N Engl J Med 1980:302:1283-1292.
92. Cohen AS. Connors LH: The pathogenesis and biochemistry of amyloidosis. J Pathol 1987;151:1-10.
93. Dcpierreux M, Goldman M. Fayl I. Richard C, Quintin J, Dhaene M, Van Hcrweghem JL: Osteoarticular amyloidosis associated with haemodialysis: An immunoultrastructural study. J Clin Pathol 1988:41:158-162.
94. Ohishi H, Skinner M, Sato AN. Okuyama T, Gejyo F. Kimura A, Cohen AS. Schmid K: Glycosaminoglvcans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver, and spleen. Clin Chem 1990; 36:88-91.
95. Aruga E. Ozasa IT Teraoka S, Ota K: Macromolecules that are colocalized with deposits ofbeta-2-microglobulin in hemodialysis-associated amyloidosis. Lab Invest 1993:69:223-230.
96. Campistol JM. Shirahama T. Abraham CR. Rodgers OG. Sole M. Cohen AS. Skinner M: Demonstration of plasma proteinase inhibitors in bcta-2-microglobulin amyloid deposits. Kidney Int 1992:42:915-923.
97. Argiles A. Mourad G, Axelrud-Cavadore C, Walrin A. Mion C, Cavadore JC: High-molecular-mass proteins in haemodialysis-associated amyloidosis. Clin Sci 1989:76:547-552.
98. Brancaccio D, Ghiggeri G. Garberi A. Anelli A. Ginevri F. Loggi G, Gusmano R: Purification and partial characterization of a new 85 kDa amyloidosis-related protein in chronic hemodialysis. Biochem Biophys Res Com-mun 1991:176:1037-1043.
99. Karlsson FA: Physical-chemical properties of beta-2-microglobulin. Immunochemistry 1974:11:111-114.
100. Cresswell P. Springer T, Stroniinger JL. Turner M. Grey HM, Kubo RT: Immunologic identity of the small subunit of HLA antigens and beta-2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci USA 1974:71:4811-4822.
101. Grey HM. Kubo RI. Colon SM. Poulik MD. Cresswell P. Springer T. Turner M. Stromin-ger JL: The small subunit of III.A antigen is bcta-2-microglobulin. J Exp Med 1973:138: 1608-1612.
102. Karlsson FA. Wibell L. Ervin PE: Beta-2-microglobulin in clinical medicine. Scand J Clin Lab Invest 1980:40:27-37.
103. De Preval C. Mach B: The absence of beta-2-niicroglobulin in Daudi cells: Active gene but inactive messenger RNA. Immunogenet-ics 1983:17:133-140.
104. Chanard J. Vincent C. Caudwell V. Lavaud S, Toupancc O, Wong T. Revillard JP: Beta-2-microglobulin metabolism in uremic patients who are undergoing dialysis. Kidney Int 1993:41:S83-S87.
105. Karlsson FA, Grolh G. Sege K, Wibell L, Peterson PA: Turnover in humans of beta-2-microglobulin: The constant chain of HLA-antigens. Eur J Clin Invest 1981:10:293-300.
106. Roegc J. Bartsch A. Schulze M, Shaldon S. Koch KM. Smeby LG: Clearance and synthesis rates of beta-2-microglobulin in patients undergoing hemodialysis and in normal subjects. J Lab Clin Med 1991:118:153-165.
107. l:5I-beta-2-microglobulin turnover in dialyzed patients. Kidney Int 1992:42:1434-1443.
108. Vincent C. Revillard JP: Serum levels and urinary excretion of beta-2-microglobulin in patients under hemodialysis or after renal transplantation. Acta Clin Belg 1980:35 (suppl 10):31-39.
109. Bernier GM. Conrad ME: Catabolism of human beta 2-microglobulin by the rat kidney. Am J Physiol 1969;217:1359-1362.
110. Flocge J, Wilks MF. Soose M. Kotzerke J, Shaldon S, Koch KM: Renal elimination of beta-2-microglobulin and myoglobin in patients with normal and impaired renal function. Nephron 1990:55:361-367.
111. Vincent C, Pözet N, Revillard JP: Plasma beta-2-microglobulin turnover in renal insufficiency. Acta Clin Belg 1980:35(suppl 10):2-13.
112. Ramadori G. Mitsch A. Rieder H. Meyer zum Biischenfelde KM: Alpha-and gamma interferon (INFa. INFy). but not interleukin I (IL-I) modulate synthesis and secretion of beia-2-microglobulin by hépatocytes. Eur J Clin Invest 1988;18:343-351.
113. Collins T. Lapierre LA, Fiers W. Slromingcr JL. Pober JS: Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A, B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sei USA 1986:83: 446-450.
114. Nachbaur K. Troppmever J. Bieling P. Kot-lan B. König P. Huber CM: Cytokines in the control of beta-2-microglobulin release. I. In vitro studies on various hematopoietic cells. Immunobiology 1988:177:55-65.
115. Nachbaur K. Troppmever J, Kotlan B. König P, Aulitzky W. Bieling P. Huber CH: Cytokines in the control of beta 2-microglobulin release. II. In vivo studies with recombinant interferons and antigens. Immunobiology 1988;177:66-75.
116. Lovett D, Kozan B, Hadam M. Resell K, Gemsa D: Macrophage cytotoxicity: lnterleu-kin-1 as a mediator of tumor cytostasis. J Immunol 1986:136:340-347.
117. Aulitzky WE, Tilg H. Herold M. Berger M. Vogel W. Judmaier G. Gastl G, Müll B. Fleuer R. Wiegele J. Pichler E. Denz II. Bö-heim E, Aulitzky WK, Huber C: Enhanced serum levels of beta 2-microglobulin, neopterin and interferon-y in patients treated with recombinant tumor necrosis factor-a. J Interferon Res 1988:8:655-664.
118. Lonnemann G. Bingel M. Koch KM. Shaldon S, Dinarello CA: Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes. Lymphokine Res 1987:6:63-70.
119. Lonnemann G. Bingel M. Floege J. Koch KM. Shaldon S. Dinarello CA: Detection of endotoxin-like interleukin-1 inducing activity during in vitro dialysis. Kidney Int 1988:33: 29-35.
120. Lonnemann G. Koch KM. Shaldon S. Dinarello CA: Studies on the ability of hemodialysis membranes to induce, bind and clear human interleukin-I J Lab Clin Med 1988:112: 76-86.
121. Lonnemann G. Behme TC, Lenzner B, Floege J. Schulze M. Colton CK. Koch KM. Shaldon S: Permeability of dialyzer membranes to TNF-u-inducing substances derived from w ater bacteria. Kidney Int 1992:42:61-69.
122. Mahiout A. Shaldon S. Koch KM: Production of endotoxin and its related subfragments in contaminated bicarbonate dialysate (abstract). J Am Soc Nephrol 1991:2:337.
123. Bingel M. Lonnemann G. Koch KM. Shaldon S: Enhancement of in vitro human interleukin-1 production by sodium acetate. Lancet 1987:Vol i: 14-16.
124. Honkanen E. Gronhagcn Riska C. Teppo AM, Maury CP. Meri S: Acute-phase proteins during hemodialysis: Correlations w ith serum interleukin-l beta levels and different dialysis membranes. Nephron 1991:57:283-287.
125. Heberlin A. Thu Nguyen A. Zingraff J. Urena P. Deschamps-Latscha B: Influence of uremia and hemodialysis on circulating interleukin-l and tumor necrosis factor-a. Kidney Int 1990; 37:116-125.
126. Haeffner-Cavaillon N, Cavaillon J. Ciano-cioni C, Bade F. Delons S. Kazatchkine M: In vivo induction of interleukin-l during hemodialysis. Kidney Int 1989:35:1212-1218.
127. Floege J. Schaffer J. Koch KM. Shaldon S: Dialysis related amyloidosis: A disease of chronic retention and inflammation? Kidney Int 1992:38:S78-S85.
128. Jalin B. Betz M. Dcppisch R. Janssen O. Ilansch GM. Ritz E: Stimulation of bcta-2-microglobulin synthesis in lymphocytes after exposure to Cuprophan dialyzer membranes. Kidney Int 1991:40:285-290.
129. Zingraff J. Bcyne P. Urena M, Uzan M. Nguyen Khoa M. Deschamps-Latscha B. Drüke T: Influence of hemodialysis membranes on beta-2-microglobulin kinetics: In vivo and in vitro studies. Nephrol Dial Trans-plant 1988:3:284-290.
130. Knudsen PJ. Leon J. Ng AK. Shaldon S. Floege J. Koch KM: Hemodialysis-related induction of beta-2-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes. Nephron 1989:53:188-193.
131. Bonucchi D. Lucchi L. Leonardi M. Cenci AM. Lusvarghi E: Cellulosic membranes and leucocytes are not effective for in vitro generation of beta-2-microglobulin (letter). Nephrol Dial Transplant 1988:3:708.
132. Shishido K. Akizawa T. Sato M. Koshikawa S: Estimation of bcta-2-microglobulin production from Ivtnphocyes in hemodialysis patients (letter). Nephron 1989;51:132-133.
133. Paczek L, Schaefer RM. Hcidland A: Dialysis membranes inhibit in vitro release of beta 2-microglobulin from human lymphocytes. Nephron 1990:56:267-270.
134. Jaoui PM. Stone WJ. Hakim RM: Effects of dialysis membranes on beta 2-microglobulin production and cellular expression. Kidney Int 1990:38:962-968.
135. Flocge J. Granolleras C. Bingel M, Deschodt G, Branger B. Ouïes R. Koch KM. Shaldon S: Beta-2-microglobulin kinetics during haemodialysis and haemofiltration. Nephrol Dial Transplant 1987:1:223-228.
136. Hauglustaine D. Waer M, Michielscn P. Goebels J. Vandeputte M: Haemodialysis membranes, serum beta-2-microglobulin. and dialysis amyloidosis (letter). Lancet 1986:Vol i: 1211-1212.
137. Bommer J. Seelig P. Seelig R. Geerlings W. Bommer G. Ritz E: Determinants of plasma beta-2-microglobulin concentration: Possible relation to membrane biocompatibility. Nephrol Dial Transplant 1987;2:22-25.
138. Floege J. Granolleras C. Mcrschcr S. Eisen-bach GM. Deschodt G, Colton CK, Shaldon S. Koch KM: Is the rise in plasma beta-2-microglobulin seen during hemodialysis meaningful? Nephron 1989:51:6-12.
139. Bergstrom J. Wchle B: No change in corrected bcta-2-microglobulin concentration after cu-prophane dialysis (letter). Lancet 1987:Vol i:628-629.
140. Chanard J. Toupance O. Lavaud S. Jaisser F, Cillery P: Serum beta-2-microglobulin and extracellular fluid volume during haemodialysis. Nephrol Dial Transplant 1989:4:549-554.
141. Hônig A. Marsden T, Sehad S. Barth C. Pol-lok M. Baldamus CA: Correcton of bcta-2-microglobulin concentration changes to distribution volume. Int J Artif Organs 1988:11: 459-464.
142. Odell RA. Slowiaczck P. Moran JE. Schind-helm K: Beta-2-microglobulin kinetics in end-stage renal failure. Kidney Int 1991:39:909-919.
143. Floege J. Granolleras C. Deschodt G. Heck M. Baudin G. Branger B, Tournier O, Reinhard B. Eisenbach GM. Smeby LC. Koch KM. Shaldon S: High-flux synthetic versus cellulosic membranes for bcta-2-microglobu-lin removal during hemodialysis, hémodiafiltration and hemofiltration. Nephrol Dial Transplant 1989:4:653-657.
144. Chanaud B, Assounga A, Ravier J L. Slingen-eyer A, Aznar R. Robinet-Lcvy M. Mion C: Beta-2-microglobulin serum levels in maintenance dialysis. Trans Am Soc Artif Intern Organs 1988:34:923-929.
145. Sethi D. Murphy CM. Brown EA. Muller BR. Gower PE: Clearance of beta-2-microglobulin using continuous ambulatory peritoneal dialysis. Nephron 1989,52:352-355.
146. Blumberg A. Bürgi W: Behavior of beta-2-microglobuiin in patients with chronic renal failure undergoing hemodialysis, hémodiafiltration and continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1987:27:245-249.
147. Sethi D. Gower PR: Dialysis arthropathy, bcta-2-microglobulin and the ell'ect of dialys-er membrane. Nephrol Dial Transplant 1988: 3:768-772.
148. Kandus A. Ponikvar R. Drinovec J. Pavlin K. Ivanovich P: Bela-2-niicroglobnlin elimination characteristics during hemofiltration with acrylonitrile and polysulfonc membrane hemofilters. Int.1 Artif Organs 1990:13:200-204.
149. Goldman M. Lagmiche M. Dhacne M, Am-raoui Z. Thayse C. Vanherwegliem JR: Adsorption of beta-2-microglobulin on dialysis membranes: Comparison of different dialyz-ers and effects of reuse procedures. Int J Artif Organs 1989:12:373-378.
150. Mineshima M. Hoshino T. Era K, Kitano Y. Suzuki T, Sanaka T, Teraoka S. Agishi T. Ota K: Difference in beta-2-microglobulin removal between ccllulosic and synthetic polymer membrane dialyzers. Trans Am Soc Artif Intern Organs 1990:36:643-646.
151. Floege J. Smeby R: Dialysis-related amyloidosis and high-llux membranes. Contrib Nephrol. Basel. Karger. 1992. vol 96. pp 124-137.
152. Canaud B. Assounga A. Kerr P. Aznar R. Mion C: Failure of daily haemofiltration programme using a highly permeable membrane to return beta-2-microglobulin concentrations to normal in haemodialysis patients. Nephrol Dial Transplant 1992:7:924-930.
153. SelliTil H. D'Agostini B. Meld E: Removal of bcta-2-microglobulin by hemodialysis and hemofiltration: A four-year follow-up. Biomater Artif Cells Immobilization Biotechnol 1992: 20:1223-1232.
154. Fischbach M. Hamel G. Koehl C, Geisert J: Beta-2-microglobulin in hemodiafiltered children: Rong-term efficiency follow-up. Nephron 1989:53:110-114.
155. Akizawa T. Kinugasa E. Kitaoka T, Koshika-wa S, Nakabayashi N. Watanabe H. Yarnawa-ki N. Kuroda Y: Removal of beta-2-micro-globulin by direct hemoperlusion with a newly developed adsorbent. Trans Am Soc Artif Intern Organs 1987:33:532-537.
156. Gejyo F. Momma N. Asegawa S. Arakawa M: A new therapeutic approach to dialysis amyloidosis: Intensive removal of beta-2-micro-globulin with adsorbent column. Artif Organs 1993:17:240-243.
157. Ticlemans C, Dratwa M, Bergntann P, Goldman M. Flantion B, Collart F. Wens R: Continuous ambulatory peritoneal dialysis vs. haemodialysis: A lesser risk of amyloidosis? Nephrol Dial Transplant 1988:3:291-294.
158. Baltz MR. Caspi D. Evans DJ. Rowe IF. Hind CRK. Pepys MB: Circulating amyloid P component is the precursor of amyloid P component in tissue amyloid deposits. Clin Exp Immunol 1986:66:691-700.
159. Pinteric R. Painter RH: Electron microscopy of serum amyloid protein in the presence of calcium: Alternative forms of assembly of pentagonal molecules in two dimensional lattices. Can J Biochent 1979;57:727-736.
160. Pepys MB. Dyck RF. De Beer FC. Skinner M, Cohen AS: Binding of serum amyloid P-com-ponent (SAP) by amyloid fibrils. Clin Exp Immunol 1979:38:284-293.
161. Pepys MB: Amyloidosis: Some recent developments. Q J Med 1988:67:283-298.
162. Argiles A, Mourad G. Atkins RC. Mion CM: New insights into the pathogenesis of hemodialysis-associated amyloidosis. Semin Dialysis 1990:3:149-152.
163. Gejyo F, Homma N, Suzuki Y, Arakawa M: Serum levels of bcta-2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis (letter). N Engl J Med 1986:314:585-586
164. Sethi D. Gower PE: Synovial-fluid beta 2-microglobulin levels in dialysis arthropathy (letter). N Engl J Med 1986:315:1419-1420.
165. Connors RH. Shirahama T. Skinner M. Fenves A. Cohen AS: In vitro formation of amyloid fibrils from intact beta 2-microglob-ulin. Biochem Biophvs Res Commun 1985: 131:1063-1068.
166. Ono K. Uchino F: Formation of amyloid-like substance from beta-2-microglobulin in vitro. Nephron 1994:66:404-407.
167. Campistol JM. Sole M. Bombi JA. Rodriguez R. Mirapeix E, Munoz Gomez J. Revert OW: In vitro spontaneous synthesis of beta-2-mi-croglobulin amyloid fibrils in peripheral blood mononuclear cell culture. Am J Pathol 1992;141:241-247.
168. Nakashima Y. Akizawa T. Nagai T. Koshika-wa S: Role of uremic and endothelial factors in the development of beta-2-microglobulin amyloidosis. Kidney Int 1993:41:S88-S95.
169. Rinke RP. Mampl II. Bartel SS. Eulitz M: Beta-2-microglobulin. different fragments and polymers thereof in synovial amyloid in long-term hemodialysis. Biol Chem Hoppe Seyler 1987:368:1371-144.
170. Rinke RP, Hampl II. Robcck II. Ritz E. Bom-mer J. Waldherr R. Eulitz M: Rysine-specific cleavage of beta-3-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int 1989:36:675-681.
171. Rinkc RP. Kcrling A, Rail A: Hemodialysis: Demonstration of truncated beta-2-micro-globulin in AB-amyloid in situ. Kidney Int 1993:41:S 100-S105.
172. Rinke RP. Floege J. Rottspeich F. Dcutzmann R: Several bcta-2-microgIobulin fragments identified in an amyloidoma in a patient with long-term hemodialysis: in Natvig.1. Forre O, Husby G. Husebekk A. Skogen B, Sielten K. Westmark P (eds): Amyloid and Amyloidosis 1990. Dordrecht. Kluwer Academic. 1991, pp 369-373.
173. Hört WH. Schaefer RM. Heidland A: Effect of different dialyzers on protéinases and proteinase inhibitors during hemodialysis. Am J Nephrol 1985:5:320-326.
174. Ravie G. Zucker-Franklin D. Franklin RC: Elastase-type proteases on the surface of human blood monocytes: Possible role in amyloid formation. J Immunol 1980:125:175-150.
175. Frangione B: Systemic and cerebral amyloidosis. Ann Med 1989;21:69-72.
176. Kisilevsky R: Amyloid and amyloidoses: Differences. common themes, and practical considerations. Mod Pathol 1991:4:514-518.
177. Odani H. Ovarna R. Titani K. Ogawa H, Sai-to A: Purification and complete amino acid sequence of novel beta 2-microglobulin. Biochem Biophvs Res Commun 1990:168:1223-1229.
178. Ogawa H. Saito A, Oda O. Nakajima M, Cluing TG: Detection of novel bcta-2-micro-globulin in the serum of hemodialysis patients and its antyloidogenic predisposition. Clin Nephrol 1988;30:158-163.
179. Miyata T, Oda O, Inagi R, Rida Y. Araki N, Yamada N. Horiuchi S. Taniguchi N. Macda K, Kinoshita T: Bcta-2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993:92:1243-1252.
180. Coggi G. Maiorano E. Braidotti P. DelTOrto P. Viale G: Beta-2-microglobulin amyloidosis in synovial membranes: Histopathology. im-munocytochemistry and electron microscopy; in Gejyo F, Brancaccio. D. Bardin T (eds): Dialysis Amyloidosis. Milan. Wichtig Edi-tore, 1989. pp 57-78.
181. Ogawa H. Saito A. Ono M: Inflammation as the possible cause of cystic radiolucencics in carpal bones of patients on hemodialysis. ASAIO Trans 1989:35:317-319.
182. Theaker JM, Raine AE. Rainey AJ. Heryet A. Clark A, Oliver DO: Systemic anyloidosis of beta-2-microglobuIin type: A complication of long-term haemodialysis. J Clin Pathol 1987: 40:1247-1251.
183. Homma N. Gejyo F. Isemura M. Arakawa M: Collagen-binding affinity of beta-2-micro-globulin, a preprotein of hemodialysis-associated amyloidosis. Nephron 1989:53:37-40.
184. Snow AD. Bramson R, Mar H, Wight TN, Kisilevsky R: A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J Ilistochem Cytochem 1991: 39:1321-1330.
185. Snow AD. Willmer J. Kisilevski R: Sulfated giycosaminogiycans: A common constitutent of all amyloids? Rab Invest 1987:56:120-123.
186. Elghethany MT. Saleem A: Methods for staining amyloid in tissue. Stain Technol 1988:63: 201-212.
187. Nishi S, Ogino S, Maruyama Y, Honna N, Gejyo F. Morita T. Arakawa M: Electron-microscopic and immunohistochemical study of beta-2-microglobulin-related amyloidosis. Nephron 1990:56:357-363.
188. Floege J: Diagnostic approaches to AB-amy-loidosis. Blood Purif 1991-.9:63-69.
189. Orila C. Goffinct F. Goudable C. Echc JP. Ton That H, Manuel Y. Sue JM: Unsuitable value of abdominal fat tissue aspirate examination for the diagnosis of amyloidosis in long-term hemodialysis patients. Am J Nephrol 1988:8:454-456.
190. Munoz-Gomez J. Gomez PR. Sole AM. Hoparl BE: Synovial fluid examination for the diagnosis of synovial amyloidosis in patients with chronic renal failure undergoing haemodialysis. Ann Rheum Dis 1987:46:324-326.
191. McMahon LP, Radford J. Dawbom JK: Shoulder ultrasound in dialysis related amyloidosis. Clin Nephrol 1991:35:227-232.
192. Kay J. Benson CB. Lester S. Corson JM. Pin-kus GS. Lazarus JM. Owen WJ: Utility of high-resolution ultrasound for the diagnosis of dialysis-related amyloidosis. Arthritis Rheum 1992:35:926-932.
193. Jadoul M. Malghem J. vande Berg B. van Ypersele de Strihou C: Ultrasonography of joint capsules and tendons in dialysis-related amyloidosis. Kidney Int 1993:41:S106-S110.
194. Grignon B. Bracard S. Abadou H, Roland J. Picad L: Long-term hemodialysis spondvlar-thropathy: An allanto-occipital location. J Neuroradiol 1990;17:60-65.
195. Miura Y, Ishiyama T. Inomata A, Takeda T. Senma S, Okuyama K, Suzuki Y: Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis. Nephron 1992;60:268-273.
196. Ross LV. Ross GJ. Mcsgarzadeh M. Edmonds PR. Bonkdarpour A: llcmodialvsis-related amyloidomas of bone. Radiology 1991;178:263-265.
197. Orzincolo C. Bedani PL. Scutellari PN. Cardona P. Trotta F. Gilli P: Destructive spondyloarthropathy and radiographic follow-up in hemodialysis patients. Skeletal Radiol 1990: 19:483-487.
198. Ullian ME, Hammond WS, Alfrey AC, Schultz A. Molitoris BA: Beta-2-microglobu-lin-associated amyloidosis in chronic hemodialysis patients with carpal tunnel syndrome. Medicine 1989;68:107-115.
199. Sethi D. Naunton MT. Brown EA. Jewkes RF. Gower PE: Technetium-99-labelled methylene diphosphonate uptake scans in patients with dialysis arthropathy. Nephron 1990:54:202-207.
200. Grateau G, Zingraff J. Fauchet M, Mundler O, Raymond P, Berthelot JM. Bardin T. Kuntz D, Drueke T: Radionuclide exploration of dialysis amyloidosis: Preliminary experience. Am J Kidney Dis 1988:11:231-237.
201. Floege J. Schaeffer J. Koch KM: Diagnosis of bcta-2-microglobulin associated amyloidosis by scintigraphy. Rev Rheum, in press.
202. Hawkins PN, Myers MJ. Lavender JP. Pcpvs MB: Diagnostic radionuclide imaging of amyloid: Biological targeting by circulating human serum amyloid P component. Lancet 1988;Vol i: 1413-1418.
203. IJ3l-serum amyloid P component. Lancet 1991:338:335-339.
204. Zingraff J. Bardin T. Noel LH. Drueke T: Lack of haemodialysis-associated amyloidosis (letter). Lancet 1991:338:1089.
205. 1311 beta-2-microglobulin scan in C'APD. Nephrol Dial Transplant 1992:7:752.
206. Schaeffer J. Burchert W. Floege J. Gielow P. Mahiout A, Nonnast-Daniel B. Shaldon S. Koch KM: Scanning for dialysis-related amyloidosis: Improved resolution and reduced radiation exposure with 11 l-indium-bcta-2-mi-croglobulin (abstract). J Am Soc Nephrol 1993;4:382.
207. Takenaka R. Fukatsu A, Matuso S, Ishikawa K. Torivama T. Kawahara H: Surgical treatment of hemodialysis-related shoulder arthropathy. Clin Nephrol 1992:38:224-230.
208. Okutsu I, Ninomiva S. Takatori Y. Hamanaka L Genba K. Ugawa Y, Schonholtz GJ. Okumura Y: Results of endoscopic management of carpal tunnel syndrome. Orthop Rev 1993:22:81-87.
209. Jadoul M. Malghem J. Pirson Y, Maldaguc B. van Ypersele deStrihou C: Effect of renal transplantation on the radiological signs of dialysis amyloid osteoarthropathy. Clin Nephrol 1989:32:194-197.
210. Campistol JM. Ponz E, Munoz Gomez J. Oppenheimer F, Ricard MJ. Vilardell J. Andreu J: Renal transplantation for dialysis amyloidosis. Transplant Proc 1992:24:118-119.
211. Nelson SR. Sharpstone P. Kingswood JC: Dose dialysis-associated amyloidosis resolve after transplantation? Nephrol Dial Transplant 1993:8:369-370.
212. Sethi D. Brown EA. Cary NR. Woodrow DF. Gower PE: Persistence of dialysis amyloid alter renal transplantation: A case report. Am J Nephrol 1989:9:173-174.
213. Sethi D, Brown EA. Perkin GD. Maini RN. Gower PE: High flux hemodialysis: Optimal treatment for dialysis arthropathy? (abstract). XXVIth Congr Eur Dial Transplant Assoc. Göteborg, abstr book 1989, p 220.
214. Hardouin P. Flipo RM. Foissac-Gegoux P. Dumont A, Dequesnoy B. Delcambre B: Dialysis-related beta-2-microglobulin arthropathy: Improvement of clinical symptoms after sw itch of dialysis membranes. Clin Rheumatol 1988:7:41-45.
215. Floege J. Koch KM: Beta-2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes. Clin Nephrol, in press.
216. Benz RL, Siegfried JW. Teehan BP: Carpal tunnel syndrome in dialysis patients: Comparison between continuous ambulatory peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 1988; 11:473-476.
217. Brunner FP. Brynger H, Ehrich JH, Fassbinder W, Geerlings W. Rizzoni G, Selwood NIL Tufvcson G. Wing AJ: Case control study on dialysis arthropathy: The influence of two different dialysis membranes: Data from the EDTA Registry. Nephrol Dial Transplant 1990;5:432-436.
218. Kessler M, Netter P, Maheut H. Wolf C. Prcitat E, l luu TC. Gaucher A: Highly permeable and biocompatiblc membranes and prevalence of dialysis-associated arthropathy (letter). Lancet 1991;337:1092-1093.
219. Baz M. Durand C, Ragon A. Jaber K. An-drieu D. Merzouk T. Purgus R, Olmcr M. Reynier JP, Berland Y: Using ultrapure water in hemodialysis delays carpal tunnel syndrome. Int J Artif Organs 1991:14:681-685.
220. Rainsboury R. et al: Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Lancet 1983;Vol ii:934-938.